One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient

BACKGROUND: In Japan, growth hormone releasing peptide-2 (GHRP-2) is clinically used as a diagnostic agent for growth hormone secretion deficiency, but the therapeutic application of GHRP-2 has not been studied in anorexia nervosa. GHRP-2 reportedly exhibits agonistic action for ghrelin receptor and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cachexia Sarcopenia Muscle
Autori principali: Haruta, Izumi, Fuku, Yuki, Kinoshita, Kazuhisa, Yoneda, Koichi, Morinaga, Akinori, Amitani, Marie, Amitani, Haruka, Asakawa, Akihiro, Sugawara, Hideki, Takeda, Yasuo, Bowers, Cyril Y, Inui, Akio
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2015
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575555/
https://ncbi.nlm.nih.gov/pubmed/26401470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12028
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi